Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Retinal Degeneration 3 (RD3) Peptid

RD3 Reaktivität: Säugetier Wirt: Synthetic BP, WB, IHC
Produktnummer ABIN938889
  • Target Alle RD3 Produkte
    RD3 (Retinal Degeneration 3 (RD3))
    Protein-Typ
    Synthetic
    Spezies
    Säugetier
    Quelle
    • 1
    Synthetic
    Applikation
    Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
    Sequenz
    GQMREAERQQ RERSNAVRKV CTGVDYSWLA STPRSTYDLS PIERLQLEDV
    Produktmerkmale
    A synthetic peptide for use as a blocking control in assays to test for specificity of RD3 antibody,
    Alternative Names: RD3 control peptide, RD3 antibody Blocking Peptide, Anti-RD3 Blocking Peptide, Retinal Degeneration 3 Blocking Peptide, C1orf36 Blocking Peptide, LCA12 Blocking Peptide, RD3, RD-3, RD 3, RD-3 Blocking Peptide, RD 3 Blocking Peptide
  • Applikationshinweise
    Optimal conditions should be determined by the investigator
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
    Buffer
    PBS
    Handhabung
    Avoid repeated freeze/thaw cycles.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20 °C long term.
  • Target
    RD3 (Retinal Degeneration 3 (RD3))
    Hintergrund
    RD3 is preferentially expressed in retina.Defects in RD3 are the cause of Leber congenital amaurosis type 12 (LCA12).
    Molekulargewicht
    23 kDa
Sie sind hier:
Kundenservice